{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:25:44Z","timestamp":1794536744434,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01766-0","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:50:04Z","timestamp":1773658204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clonal hematopoiesis, inflammaging, and vascular disease: mechanisms, risk stratification, and therapeutic frontiers in older adults"],"prefix":"10.1038","author":[{"given":"Xi-Long","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"1766_CR1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576\u201390.","journal-title":"Nat Rev Endocrinol"},{"key":"1766_CR2","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488\u201398.","journal-title":"N Engl J Med"},{"key":"1766_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111\u201321.","journal-title":"N Engl J Med"},{"key":"1766_CR4","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477\u201387.","journal-title":"N Engl J Med"},{"key":"1766_CR5","first-page":"805","volume":"2","author":"PJ Rauch","year":"2023","unstructured":"Rauch PJ, Gopakumar J, Silver AJ, Nachun D, Ahmad H, McConkey M, et al. Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes. Nat Cardiovasc Res. 2023;2:805\u201318.","journal-title":"Nat Cardiovasc Res"},{"key":"1766_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355:842\u20137.","journal-title":"Science"},{"key":"1766_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood. 2017;130:742\u201352.","journal-title":"Blood"},{"key":"1766_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","volume":"17","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S, Libby P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol. 2020;17:137\u201344.","journal-title":"Nat Rev Cardiol"},{"key":"1766_CR9","first-page":"283","volume":"110","author":"MT Villaume","year":"2025","unstructured":"Villaume MT, Savona MR. Pathogenesis and inflammaging in myelodysplastic syndrome. Haematologica. 2025;110:283\u201399.","journal-title":"Haematologica"},{"key":"1766_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171002","volume":"134","author":"C Quin","year":"2024","unstructured":"Quin C, DeJong EN, Cook EK, Luo YZ, Vlasschaert C, Sadh S, et al. Neutrophil-mediated innate immune resistance to bacterial pneumonia is dependent on Tet2 function. J Clin Invest. 2024;134:e171002.","journal-title":"J Clin Invest"},{"key":"1766_CR11","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/j.cell.2024.05.003","volume":"187","author":"H Wang","year":"2024","unstructured":"Wang H, Divaris K, Pan B, Li X, Lim JH, Saha G, et al. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024;187:3690\u20133711.e19.","journal-title":"Cell"},{"key":"1766_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"71","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M, et al. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome. J Am Coll Cardiol. 2018;71:875\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"1766_CR13","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1182\/blood.2020007401","volume":"138","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li W, Schulz VP, Zhao H, Qu X, Qi Q, et al. Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency. Blood. 2021;138:1615\u201327.","journal-title":"Blood"},{"key":"1766_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","volume":"7","author":"EC Svensson","year":"2022","unstructured":"Svensson EC, Madar A, Campbell CD, He Y, Sultan M, Healey ML, et al. TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol. 2022;7:521\u20138.","journal-title":"JAMA Cardiol"},{"key":"1766_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026154","volume":"11","author":"KD Min","year":"2022","unstructured":"Min KD, Polizio AH, Kour A, Thel MC, Walsh K. Experimental ASXL1-mediated clonal hematopoiesis promotes inflammation and accelerates heart failure. J Am Heart Assoc. 2022;11:e026154.","journal-title":"J Am Heart Assoc"},{"key":"1766_CR16","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s44161-024-00579-w","volume":"3","author":"N Sato","year":"2024","unstructured":"Sato N, Goyama S, Chang YH, Miyawaki M, Fujino T, Koide S, et al. Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity. Nat Cardiovasc Res. 2024;3:1568\u201383.","journal-title":"Nat Cardiovasc Res"},{"key":"1766_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s44161-022-00206-6","volume":"2","author":"SM Zekavat","year":"2023","unstructured":"Zekavat SM, Viana-Huete V, Matesanz N, Jorshery SD, Zuriaga MA, Uddin MM, et al. TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Nat Cardiovasc Res. 2023;2:144\u201358.","journal-title":"Nat Cardiovasc Res"},{"key":"1766_CR18","doi-asserted-by":"publisher","first-page":"e2351927","DOI":"10.1001\/jamanetworkopen.2023.51927","volume":"7","author":"S Saadatagah","year":"2024","unstructured":"Saadatagah S, Uddin MM, Weeks LD, Niroula A, Ru M, Takahashi K, et al. Clonal hematopoiesis risk score and all-cause and cardiovascular mortality in older adults. JAMA Netw Open. 2024;7:e2351927.","journal-title":"JAMA Netw Open"},{"key":"1766_CR19","doi-asserted-by":"publisher","unstructured":"Musson EN, Hoade Y, Dace P, Herrero J, Denaxas S, Steptoe A, et al. Analysis of the effects of statin therapy on clonal dynamics in clonal haematopoiesis of indeterminate potential: insights from the English Longitudinal Study of Ageing. medRxiv Preprint 2025 https:\/\/doi.org\/10.1101\/2025.04.15.25325668.","DOI":"10.1101\/2025.04.15.25325668"},{"key":"1766_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","volume":"4","author":"L Dorsheimer","year":"2019","unstructured":"Dorsheimer L, Assmus B, Rasper T, Ortmann CA, Ecke A, Abou-El-Ardat K, et al. Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol. 2019;4:25\u201333.","journal-title":"JAMA Cardiol."},{"key":"1766_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","volume":"123","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, Katanasaka Y, Sano M, Walsh K. CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circ Res. 2018;123:335\u201341.","journal-title":"Circ Res"},{"key":"1766_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171634","volume":"136","author":"WT Abplanalp","year":"2025","unstructured":"Abplanalp WT, Raddatz MA, Schuhmacher B, Mas-Peiro S, Zuriaga MA, Matesanz N, et al. Clonal hematopoiesis activates pro-calcific pathways in macrophages and promotes aortic valve stenosis. J Clin Invest. 2025;136:e171634.","journal-title":"J Clin Invest"},{"key":"1766_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jamacardio.2024.0459","volume":"9","author":"S Saadatagah","year":"2024","unstructured":"Saadatagah S, Naderian M, Uddin M, Dikilitas O, Niroula A, Schuermans A, et al. Atrial fibrillation and clonal hematopoiesis in TET2 and ASXL1. JAMA Cardiol. 2024;9:497\u2013506.","journal-title":"JAMA Cardiol"},{"key":"1766_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366:eaan4673.","journal-title":"Science"},{"key":"1766_CR25","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton KL, Ptashkin RN, Gao T, Braunstein L, Devlin SM, Kelly D, et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet. 2020;52:1219\u201326.","journal-title":"Nat Genet"},{"key":"1766_CR26","doi-asserted-by":"crossref","unstructured":"Hosseini M, Chan SM. Novel and emerging therapeutic strategies for clonal haematopoiesis. Haematologica. 2025. doi: 10.3324\/haematol.2025.287443.","DOI":"10.3324\/haematol.2025.287443"},{"key":"1766_CR27","first-page":"24","volume":"7","author":"RA de Boer","year":"2021","unstructured":"de Boer RA, Aboumsallem JP, Bracun V, Leedy D, Cheng R, Patel S, et al. A new classification of cardio-oncology syndromes. Cardiooncology. 2021;7:24.","journal-title":"Cardiooncology"},{"key":"1766_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2459\/JCM.0000000000001744","volume":"26","author":"F Ballacci","year":"2025","unstructured":"Ballacci F, Giordano F, Conte C, Telesca A, Collini V, Imazio M. Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials. J Cardiovasc Med (Hagerstown). 2025;26:359\u201368.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"1766_CR29","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383:1838\u201347.","journal-title":"N Engl J Med"},{"key":"1766_CR30","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381:2497\u2013505.","journal-title":"N Engl J Med"},{"key":"1766_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11357-018-0042-y","volume":"40","author":"JN Justice","year":"2018","unstructured":"Justice JN, Ferrucci L, Newman AB, Aroda VR, Bahnson JL, Divers J, et al. A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup. Geroscience. 2018;40:419\u201336.","journal-title":"Geroscience"},{"key":"1766_CR32","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s11357-022-00671-8","volume":"44","author":"SR Cummings","year":"2022","unstructured":"Cummings SR, Kritchevsky SB. Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age. Geroscience. 2022;44:2925\u201331.","journal-title":"Geroscience"},{"key":"1766_CR33","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1016\/j.cell.2023.08.003","volume":"186","author":"M Moqri","year":"2023","unstructured":"Moqri M, Herzog C, Poganik JR, Justice J, Belsky DW, Higgins-Chen A, et al. Biomarkers of aging for the identification and evaluation of longevity interventions. Cell. 2023;186:3758\u201375.","journal-title":"Cell"},{"key":"1766_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","volume":"393","author":"Collaboration CTT","year":"2019","unstructured":"Collaboration CTT. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393:407\u201315.","journal-title":"Lancet"},{"key":"1766_CR35","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, Jansen T, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW, et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2020;2:e270\u2013e80.","journal-title":"Lancet Rheumatol"},{"key":"1766_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43697-y","volume":"14","author":"J McClatchy","year":"2023","unstructured":"McClatchy J, Strogantsev R, Wolfe E, Lin HY, Mohammadhosseini M, Davis BA, et al. Clonal hematopoiesis related TET2 loss-of-function impedes IL1\u03b2-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells. Nat Commun. 2023;14:8102.","journal-title":"Nat Commun"},{"key":"1766_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","volume":"592","author":"TP Fidler","year":"2021","unstructured":"Fidler TP, Xue C, Yalcinkaya M, Hardaway B, Abramowicz S, Xiao T, et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature. 2021;592:296\u2013301.","journal-title":"Nature"},{"key":"1766_CR38","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","volume":"34","author":"AAZ Dawoud","year":"2020","unstructured":"Dawoud AAZ, Tapper WJ, Cross NCP. Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking. Leukemia. 2020;34:2660\u201372.","journal-title":"Leukemia"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01766-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:50:08Z","timestamp":1773658208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01766-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":38,"alternative-id":["1766"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01766-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}